KMT2D and cancer: However, more studies indicate that MLL3 and MLL4 are also capable of binding to promoter regions (Chen et al., 2014; Dhar et al., 2016; Wang et al., 2010), especially in the context of cancer (Soto-Feliciano et al., 2023).